Anand Patel: The final version of intensive chemo strategies in CBF-AML
Anand Patel, Assistant Professor and Director of the Inpatient Leukemia Service at the University of Chicago, posted on X about recent paper by Alexandra Rojek et al., titled “Real-world outcomes of intensive induction approaches in core binding factor acute myeloid leukemia” published on eJHaem Journal.
Authors: Alexandra E. Rojek, Benjamin J. McCormick, Joanna Cwykiel, Oluwatobi Odetola, Yasmin Abaza, Nhi Nai, Charles E. Foucar, Rohan K. Achar, Rory M. Shallis, Danielle Bradshaw, Meaghan Standridge, Vamsi Kota, Guru Subramanian, Guru Murthy, Talha Badar, Anand A. Patel
“The final version of our eJHaem Journal paper on intensive chemo strategies in CBF-AML is available!
- 3y OS 70% and 3y EFS 51% for entire cohort
- IC + GO 3y EFS 50%, IC alone 3y EFS 47%, IC + KIT inhibitor 3y EFS 85%.”
Quoting his own post below:
“Our analysis of intensive chemo (IC) in CBF-AML (200 pt) is out in eJHaem Journal ! Kudos to lead author Alexandra Rojek
We found:
- similar EFS/OS betw IC + GO & IC alone
- longer 3y EFS with IC + KIT inhibitor (85%)
We eagerly await NCT02013648 results!”
Source: Anand Patel/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023